Evidence map›Paper›PMID 33954206›Full record

ArticleJournal of immunology research2021

Invariant Natural Killer T Cells as Key Players in Host Resistance against

Joes Nogueira-Neto, Flavio V Loures, Alessandra S Schanoski, David A G Andrade, Michelangelo B Gonzatti, Tania A Costa, Bruno C Vivanco, Patrícia Xander, Daniela S Rosa, Vera L G Calich and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Joes Nogueira-NetoDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.ORCID https://orcid.org/0000-0001-7090-2833
Flavio V LouresDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.ORCID https://orcid.org/0000-0001-7711-4063
Alessandra S SchanoskiDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.ORCID https://orcid.org/0000-0002-6514-8458
David A G AndradeDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.ORCID https://orcid.org/0000-0002-4794-9411
Michelangelo B GonzattiDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.ORCID https://orcid.org/0000-0003-3310-6576
Tania A CostaDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.
Bruno C VivancoDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.ORCID https://orcid.org/0000-0001-6390-307X
Patrícia XanderDepartamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Campus Diadema, Brazil.ORCID https://orcid.org/0000-0002-6329-6449
Daniela S RosaDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.ORCID https://orcid.org/0000-0003-4536-891X
Vera L G CalichDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.ORCID https://orcid.org/0000-0002-2170-5099
Alexandre C KellerDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.ORCID https://orcid.org/0000-0002-7827-0292
Universidade Federal de São Paulo · BRUniversidade de São Paulo · BRInstituto de Ciências Farmacêuticas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invariant Natural Killer T (iNKT) cells are key players in the immunity to several pathogens; however, their involvement in the resistance to

Indexed as

Disease ResistanceAnimalsAntigens, CD1dDisease Models, AnimalHumansImmunity, InnateMaleMiceMice, Inbred C57BLMice, KnockoutNatural Killer T-CellsParacoccidioidesParacoccidioidomycosisReceptors, Antigen, T-Cell, alpha-betaAntigens, CD1dCD1d antigen, mouseReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID33954206
PMCPMC8064773
OpenAlexW3152492725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.